Glenmark'S Current Portfolio Consists Of 173 Products Authorised For Distribution In The Us Marketplace And 46 Anda'S Pending Approval With The Usfda.Glenmark Pharmaceuticals On Friday Said Its Us-Based Unit Has Received Approval From The Us Health Regulator To Market Metronidazole Vaginal Gel, In The American Market. The Drug Firm Has Received Final Approval By The United States Food & Drug Administration (Usfda) For Its Product Which Is A Generic Version Of Bausch Health Us Llc'S Metrogel-Vaginal, The Drug Firm Said In A Statement. According To Iqvia Sales Data For The 12-Month Period Ending November 2021, The Metrogel-Vaginal Gel Achieved Annual Sales Of Approximately Around Usd 60.4 Million Glenmark'S Current Portfolio Consists Of 173 Products Authorised For Distribution In The Us Marketplace And 46 Anda'S Pending Approval With The Usfda. In Addition To These Internal Filings, The Drug Firm Continues To Identify And Explore External Development Partnerships To Supplement And Accelerate The Growth Of Its Existing Pipeline And Portfolio, Glenmark Noted.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!